Goldman Sachs
NARI

Goldman Sachs’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Goldman Sachs’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-550,942
Closed -$28.1M – 6502
2024
Q4 		$28.1M Buy
550,942
+275,005
+100% +$13.5M ﹤0.01% 1801
2024
Q3 		$11.4M Sell
275,937
-58,688
-18% -$2.82M ﹤0.01% 2588
2024
Q2 		$16.1M Buy
334,625
+93,007
+38% +$4.12M ﹤0.01% 2055
2024
Q1 		$11.6M Buy
241,618
+59,969
+33% +$3.2M ﹤0.01% 2347
2023
Q4 		$11.8M Sell
181,649
-6,296
-3% -$379K ﹤0.01% 2378
2023
Q3 		$12.3M Sell
187,945
-621,824
-77% -$39.1M ﹤0.01% 2215
2023
Q2 		$47.1M Buy
809,769
+330,296
+69% +$20.8M 0.01% 1152
2023
Q1 		$29.6M Sell
479,473
-82,313
-15% -$4.94M 0.01% 1457
2022
Q4 		$35.7M Buy
561,786
+119,280
+27% +$8.65M 0.01% 1448
2022
Q3 		$32.1M Buy
442,506
+133,928
+43% +$9.97M 0.01% 1451
2022
Q2 		$21M Sell
308,578
-5,602
-2% -$403K 0.01% 1856
2022
Q1 		$28.5M Buy
314,180
+148,575
+90% +$12.2M 0.01% 1758
2021
Q4 		$15.1M Buy
165,605
+107,593
+185% +$9.22M ﹤0.01% 2380
2021
Q3 		$4.7M Sell
58,012
-2,683
-4% -$225K ﹤0.01% 3421
2021
Q2 		$5.66M Buy
60,695
+32,952
+119% +$3.19M ﹤0.01% 3226
2021
Q1 		$2.97M Sell
27,743
-14,700
-35% -$1.53M ﹤0.01% 3598
2020
Q4 		$3.71M Buy
+42,443
New +$3M ﹤0.01% 3245
2020
Q3 		– Sell
-41,805
Closed -$2.02M – 5573
2020
Q2 		$2.02M Buy
+41,805
New +$2M ﹤0.01% 3451

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Goldman Sachs's NARI Position: Q1 2025 in Review

Goldman Sachs sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 550,942 shares — an estimated $28.1M sold.

Goldman Sachs first reported a position in NARI in Q2 2020 and held it in 18 quarters. The position peaked at $47.1M in Q2 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Goldman Sachs reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Goldman Sachs sold 550,942 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $28.1M.
  • Goldman Sachs first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 18 quarters.
  • Goldman Sachs's Inari Medical, Inc. Common Stock position peaked at $47.1M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.